“miRNA-486 and miRNA-499 in human plasma evaluate the clinical stages of lung cancer and play a role as a tumor suppressor in lung tumorigeneisis not pathogenesis”, Bangladesh J Pharmacol, vol. 11, no. 1, pp. 264–268, Jan. 2016, doi: 10.3329/bjp.v11i1.25318.